Delivery Order SPE2DB25D3012-SPE2DB25FWYSY

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. The $25,676.04 firm fixed price contract has a completion date of June 6, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor on this order and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Skyrizi 150 mg/mL pre-filled pens, a medication used to treat certain medical conditions. The contract has a ceiling value of $14,061.53 and a performance period ending on May 1, 2025. It is a firm-fixed-price contract type. The contract is not set aside for any specific...

This is a $24,635.40 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SKYRIZI 150 MG/ML PENML, a medication, with a period of performance through June 11, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...

This is a $80,346.15 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a performance period through July 2025. This award is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,827.51, is for the delivery of SKYRIZI 150 MG/ML PENML, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 5, 2024. The award is not designated with a set-aside requirement, indicating...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,833.13 firm-fixed-price contract is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a period of performance through May 27, 2025. The award is not associated with a set-aside program and is part of AmerisourceBergen's broader federal contracting relationship with the DLA....

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 150 MG/ML SYRINGE medical product, with a firm fixed price ceiling value of $12,604.63. The contract has an ultimate completion date of May 2, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $40,131.35, is for the supply of SKYRIZI 150 MG/ML PENML, a prescription medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...

This is a $11,830.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML medical products. The award is not set aside for any specific socioeconomic program. The contract has an ultimate completion date of July 8, 2025 and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. The contract has a firm fixed price, with a ceiling value of $26,327.15, and a performance period ending on May 23, 2025. AmerisourceBergen Drug Corp is delivering these pharmaceutical products under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...